Santa Cruz Biotechnology

IL-8 (A-6) | Santa Cruz Biotechnology

mouse monoclonal IgG1; Interleukin-8, or IL-8, the prototypic member of the C-X-C, or a, family of chemokines, is a chemoattractant cytokine involved in the chemotaxis and activation of neutrophils. IL-8 expression has been correlated to a large number of chronic inflammatory diseases, including inflammatory bowel disease (IBD) and atherosclerosis. IL-8 is cleaved from a 99 amino acid precursor to a 72 amino acid, nonglycosylated, biologically active protein. IL-8 monomers and dimers exhibit a dynamic equilibrium both free in solution and in cell surface-bound forms and thus regulate chemotaxis and receptor signaling. Research has shown that IL-8 dimerization functions as a negative regulator for IL-8 receptor function. Two IL-8 receptors, designated IL-8RA and IL-8RB, have been described and share 77% sequence identity. Both are seven-transmembrane domain proteins (7TMD), similar to the G protein-coupled receptors and, in addition to IL-8, serve as receptors for other members of the a and b chemokine families.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.